Gabelli Funds’s Axonics, Inc. Common Stock AXNX Stock Holding History

Gabelli Funds’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-275,594	Closed	-$19.2M	–	1139
2024 Q3	$19.2M	Buy	275,594 +1,619	+0.6%	+$111K	0.14%	207
2024 Q2	$18.4M	Buy	273,975 +96,050	+54%	+$6.47M	0.14%	196
2024 Q1	$12.3M	Buy	+177,925	New	+$12M	0.09%	281

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli Funds's AXNX Position: Q4 2024 in Review

Gabelli Funds sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 275,594 shares — an estimated $19.2M sold.

Gabelli Funds first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $19.2M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Gabelli Funds reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Gabelli Funds sold 275,594 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $19.2M.
Gabelli Funds first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Gabelli Funds's Axonics, Inc. Common Stock position peaked at $19.2M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Gabelli Funds's 13F filing for Q4 2024, filed 13 Feb 2025.